|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.00 EUR | -1.32% |
|
+7.04% | -0.65% |
| May. 11 | Bio-K+ Advances Research on Gut Health and Autism Spectrum Disorder with Clinical Study Findings | CI |
| May. 01 | Kerry Group plc, Q1 2026 Interim Management Statement Call, Apr 30, 2026 |
| Market Cap | 12.23B 14.1B 11.28B 10.57B 19.74B 1,350B 20.15B 135B 52.08B 651B 52.92B 51.78B 2,262B | P/E Ratio 2026 * |
16.8x | P/E Ratio 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 14.19B 16.36B 13.08B 12.26B 22.91B 1,566B 23.38B 156B 60.43B 755B 61.4B 60.08B 2,625B | EV / Sales 2026 * |
2.09x | EV / Sales 2027 * | 1.96x |
| Free-Float |
99.85% | Yield 2026 * |
1.99% | Yield 2027 * | 2.19% |
Last Transcript: Kerry Group plc
| May. 18 | Kerry : EFSA publishes positive scientific opinion on Kerry’s Acrylerase, a first-of-... | PU |
| Apr. 30 | Kerry : AGM 2026 Special business | PU |
| Apr. 30 | Kerry : AGM 2026 Proxy votes received | PU |
| Apr. 30 | Kerry : AGM 2026 – Proxy Votes Received | PU |
| Apr. 30 | Kerry : AGM 2026 – Special Business | PU |
| 1 week | +7.04% | ||
| Current month | +4.83% | ||
| 1 month | +6.29% | ||
| 3 months | +9.35% | ||
| 6 months | +1.33% | ||
| Current year | -0.65% |
| 1 week | 69.5 | 76 | |
| 1 month | 68.5 | 76 | |
| 3 years | 62.5 | 102 | |
| 5 years | 62.5 | 127 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edmond Scanlon
CEO | Chief Executive Officer | 52 | 2017-09-30 |
| Director of Finance/CFO | 55 | 2018-09-29 | |
Alan Barrett
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Edmond Scanlon
BRD | Director/Board Member | 52 | 2017-09-30 |
| Director/Board Member | 66 | 2018-05-07 | |
| Director/Board Member | 55 | 2018-09-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.32% | +7.04% | -21.65% | -16.02% | 14.13B | ||
| -0.38% | +3.59% | -6.73% | -25.88% | 257B | ||
| -0.90% | +4.34% | -4.94% | -12.59% | 82.38B | ||
| -0.51% | +3.68% | -9.71% | +22.65% | 49.07B | ||
| -0.79% | -3.41% | +65.46% | +10.06% | 39.17B | ||
| +1.96% | -1.48% | +7.12% | -29.46% | 35.82B | ||
| -1.14% | +2.09% | +16.94% | +28.74% | 29.11B | ||
| +7.51% | -2.74% | +39.86% | +80.06% | 28.2B | ||
| +0.64% | +7.72% | -8.38% | -33.83% | 28.52B | ||
| -0.08% | -1.05% | +69.69% | +36.54% | 24.88B | ||
| Average | +0.72% | +0.02% | +14.76% | +6.03% | 63.8B | |
| Weighted average by Cap. | +0.13% | +1.73% | +5.12% | -7.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.78B 7.81B 6.25B 5.85B 10.94B 748B 11.17B 74.53B 28.86B 361B 29.32B 28.69B 1,253B | 7.06B 8.14B 6.51B 6.1B 11.4B 779B 11.63B 77.64B 30.06B 376B 30.55B 29.89B 1,306B |
| Net income | 721M 831M 665M 623M 1.16B 79.56B 1.19B 7.93B 3.07B 38.35B 3.12B 3.05B 133B | 794M 915M 732M 686M 1.28B 87.61B 1.31B 8.73B 3.38B 42.23B 3.43B 3.36B 147B |
| Net Debt | 1.96B 2.26B 1.81B 1.69B 3.17B 216B 3.23B 21.57B 8.35B 104B 8.49B 8.3B 363B | 1.62B 1.87B 1.49B 1.4B 2.62B 179B 2.67B 17.83B 6.9B 86.25B 7.02B 6.86B 300B |
| Date | Price | Change |
|---|---|---|
| 26-06-11 | 75.00 € | -1.32% |
| 26-06-10 | 76.00 € | +2.01% |
| 26-06-09 | 74.50 € | +4.20% |
| 26-06-08 | 71.50 € | +1.42% |
| 26-06-05 | 70.50 € | -0.70% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KRZ Stock
- KRZA Stock
Select your edition
All financial news and data tailored to specific country editions



















